All In Biotech

Drug Trial Radar · NCT00095238

Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)

Last checked: Nov 19, 2026Latest source record: Apr 7, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 4,128 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

4,128

Actual

Start

Jun 2002

Primary completion

Jul 2008

Study completion Jul 2008

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
Collaborators
Sanofi
First posted
Nov 2, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical research study is to learn if Irbesartan is superior to placebo in reducing mortality and cardiovascular morbidity in subjects with heart failure with preserved systolic function. The safety of this treatment will also be studied.

Conditions

  • Congestive Heart Failure

Interventions

  • IrbesartanDrug

    Tablets, Oral, titration from 75 to 300 mg, once daily up to 6 years

  • PlaceboDrug

    Tablets, Oral, titration from 75 to 300 mg, once daily up to 6 years

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With First Occurrence of the Composite Outcome of Death (All Cause) or Protocol-Specified Cardiovascular (CV) Hospitalization at Given TimepointsTime frame: Year 1, Year 2, Year 3, Year 4, Year 5

Locations

229 sites in 25 countries. Site status is shown where the registry gives one.

  • Local Institution

    Birmingham, Alabama

  • Local Institution

    Peoria, Arizona

  • Local Institution

    Tucson, Arizona

  • Local Institution

    Little Rock, Arkansas

  • Local Institution

    Los Angeles, California

  • Local Institution

    San Diego, California

  • Local Institution

    San Francisco, California

  • Local Institution

    Farmington, Connecticut

  • Local Institution

    Jacksonville, Florida

  • Local Institution

    Jacksonville Beach, Florida

  • Local Institution

    Lake Worth, Florida

  • Local Institution

    Tampa, Florida

  • Local Institution

    Vero Beach, Florida

  • Local Institution

    Chicago, Illinois

  • Local Institution

    Peoria, Illinois

  • Local Institution

    Jeffersonville, Indiana

  • Local Institution

    Louisville, Kentucky

  • Local Institution

    Chalmette, Louisiana

  • Local Institution

    Shreveport, Louisiana

  • Local Institution

    Auburn, Maine

  • Local Institution

    Takoma Park, Maryland

  • Local Institution

    Towson, Maryland

  • Local Institution

    Boston, Massachusetts

  • Local Institution

    Haverhill, Massachusetts

  • Local Institution

    Natick, Massachusetts

  • Local Institution

    Detroit, Michigan

  • Local Institution

    Petoskey, Michigan

  • Local Institution

    Minneapolis, Minnesota

  • Local Institution

    St Louis, Missouri

  • Local Institution

    Omaha, Nebraska

  • Local Institution

    Reno, Nevada

  • Local Institution

    Lebanon, New Hampshire

  • Local Institution

    Elmer, New Jersey

  • Local Institution

    Albuquerque, New Mexico

  • Local Institution

    Albany, New York

  • Local Institution

    East Syracuse, New York

  • Local Institution

    Flushing, New York

  • Local Institution

    Rochester, New York

  • Local Institution

    The Bronx, New York

  • Local Institution

    Troy, New York

Showing 40 of 229 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.